Albemarle Corporation (BVMF:A1LB34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 87.23B +73.5% |
| Revenue (ttm) | 30.61B +18.3% |
| Net Income | 297.52M |
| EPS | 2.53 |
| Shares Out | n/a |
| PE Ratio | 293.19 |
| Forward PE | 12.70 |
| Dividend | 0.23 (0.75%) |
| Ex-Dividend Date | Sep 10, 2026 |
| Volume | 10,427 |
| Open | 28.66 |
| Previous Close | 29.25 |
| Day's Range | 28.66 - 30.95 |
| 52-Week Range | 16.26 - 45.15 |
| Beta | 1.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Albemarle
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions ... [Read more]
Financial Performance
In 2025, Albemarle's revenue was $5.14 billion, a decrease of -4.37% compared to the previous year's $5.38 billion. Losses were -$677.38 million, -48.53% less than in 2024.
Financial numbers in USD Financial StatementsNews
Albemarle Slides: Investor presentation
Albemarle has posted slides in relation to its latest quarterly earnings report, which was published on August 12, 2026.
Albemarle price target lowered to $190 from $200 at Scotiabank
Scotiabank analyst Ben Isaacson lowered the firm’s price target on Albemarle (ALB) to $190 from $200 and keeps an Outperform rating on the shares. Scotiabank encourages investors to buy Albemarle…
Albemarle price target lowered to $161 from $189 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Albemarle (ALB) to $161 from $189 and keeps an Equal Weight rating on the shares. Lithium prices have come…
Albemarle price target lowered to $225 from $245 at Truist
Truist analyst Peter Osterland lowered the firm’s price target on Albemarle (ALB) to $225 from $245 and keeps a Buy rating on the shares. Albemarle continues to execute on cost…
Albemarle price target lowered to $175 from $205 at UBS
UBS lowered the firm’s price target on Albemarle (ALB) to $175 from $205 and keeps a Buy rating on the shares.
Albemarle price target lowered to $175 from $225 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on Albemarle (ALB) to $175 from $225 and keeps a Buy rating on the shares.
Albemarle Earnings Call Transcript: Q2 2026
Q2 2026 saw net sales rise 31% year-over-year to $1.7 billion, with adjusted EBITDA more than doubling and strong cash generation. The outlook was raised for specialties, while energy storage volumes are expected to be flat to slightly down due to a plant fire, offset by JV outperformance.
Albemarle Earnings release: Q2 2026
Albemarle released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Albemarle Slides: Q2 2026
Albemarle has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Albemarle Quarterly report: Q2 2026
Albemarle has published its Q2 2026 quarterly earnings report on August 6, 2026.
Albemarle price target lowered to $160 from $185 at Mizuho
Mizuho lowered the firm’s price target on Albemarle (ALB) to $160 from $185 and keeps a Neutral rating on the shares.
Albemarle reports Q2 adjusted EPS $3.75, consensus $3.24
Reports Q2 revenue $1.7B, consensus $1.63B. “Albemarle (ALB) delivered another quarter of strong results, reflecting improved pricing, continued strength in Specialties, disciplined cost and productiv...
Albemarle raises FY26 Specialties net sales outlook to $1.4B-$1.6B
Albemarle (ALB) said: “Improving full-year 2026 outlook considerations including, increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325...
Albemarle Reports Second Quarter 2026 Results
CHARLOTTE, N.C., Aug. 5, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its resu...
Albemarle price target lowered to $200 from $215 at Scotiabank
Scotiabank analyst Ben Isaacson lowered the firm’s price target on Albemarle (ALB) to $200 from $215 and keeps an Outperform rating on the shares. The firm is updating its price…
Albemarle Appoints Eduardo Bartolomeo to Board of Directors
CHARLOTTE, N.C., July 23, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that it...
Albemarle Announces Quarterly Common Stock Dividend
CHARLOTTE, N.C., July 21, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share.
Albemarle price target lowered to $166 from $257 at RBC Capital
RBC Capital lowered the firm’s price target on Albemarle (ALB) to $166 from $257 and keeps an Outperform rating on the shares as part of a broader research note previewing…
Albemarle price target lowered to $155 from $225 at BofA
BofA analyst Matthew DeYoe lowered the firm’s price target on Albemarle (ALB) to $155 from $225 and keeps a Buy rating on the shares. With industrial growth holding in and…
Albemarle Corporation to Release Second Quarter 2026 Earnings Results on Wednesday, August 5, 2026
CHARLOTTE, N.C., July 7, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it ...
Albemarle price target lowered to $185 from $205 at Mizuho
Mizuho lowered the firm’s price target on Albemarle (ALB) to $185 from $205 and keeps a Neutral rating on the shares. The firm lowered price targets for most of its…
Albemarle upgraded to Buy from Neutral at Citi
Citi analyst Patrick Cunningham upgraded Albemarle (ALB) to Buy from Neutral with an unchanged price target of $225. The company will benefit from “structural lithium demand tailwinds,” the analyst te...
Albemarle price target raised to $257 from $253 at RBC Capital
RBC Capital raised the firm’s price target on Albemarle (ALB) to $257 from $253 and keeps an Outperform rating on the shares. The firm believes that the company should continue…
Albemarle upgraded to Buy from Hold at Vertical Research
Vertical Research upgraded Albemarle (ALB) to Buy from Hold with a $224 price target